About

Subscribe

Contact

Psychedelic-Assisted Therapy

Psychedelic-assisted therapy is gaining momentum in clinical settings, with compounds like psilocybin, MDMA, and DMT being studied for their potential to treat PTSD, anxiety, depression, and addiction. This section explores trial data, therapeutic frameworks, FDA designations, and the evolving ethics around integration into psychiatric practice.

psychedelic-assisted therapy

Exploring Psychedelic-Assisted Therapy for Depression and Burnout

October 24, 2025

psychedelic-assisted therapy insights

How Psychedelic-Assisted Therapy Is Redefining Mental Health Care

October 20, 2025

psychedelics for brain injury

Psychedelics for Brain Injury

October 17, 2025

Psychedelic-Assisted Therapy

Non-Hallucinogenic Psychedelic Analog Shows New Path to Brain Plasticity

October 15, 2025

Ketamine

Ketamine and Psilocybin Therapy in Youth: Exploring New Frontiers for Mental Health

October 13, 2025

Psilocybin Therapy

Psilocybin for Treatment-Resistant Depression Shows Long-Lasting Relief

October 8, 2025

Psychotherapy

Psilocybin-Assisted Psychotherapy for Methamphetamine Use Disorder

October 4, 2025

child holding toy

Ketamine and Psilocybin Therapy in Youth: New Hope for Tough-to-Treat Mental Health Conditions

September 26, 2025

MDMA-assisted therapy for PTSD

FDA Decision on MDMA-Assisted Therapy for PTSD Sparks Debate

September 24, 2025

Evolving Psychotherapies for PTSD: Exploring New Horizons

September 15, 2025

Back Next

Categories

Latest Articles

Join Our Email List

Sign up to receive the latest articles right in your inbox.